 | | ZZJ | | 表記: | N^2^-methyl-L-alaninamide | | 組成式: | C4 H10 N2 O | | SMILES: | O=C(N)C(NC)C | | InChi: | InChI=1S/C4H10N2O/c1-3(6-2)4(5)7/h3,6H,1-2H3,(H2,5,7)/t3-/m0/s1 | | 定義日: | 2009-09-02 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | N~2~-methyl-L-alaninamide |
|
 | | XCN | | 表記: | S-cyano-L-cysteine | | 組成式: | C4 H6 N2 O2 S | | SMILES: | O=C(O)C(N)CSC#N | | InChi: | InChI=1S/C4H6N2O2S/c5-2-9-1-3(6)4(7)8/h3H,1,6H2,(H,7,8)/t3-/m0/s1 | | 定義日: | 2010-09-21 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | S-cyano-L-cysteine |
|
 | | YVD | | 表記: | 4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide | | 組成式: | C29 H36 F2 N4 O5 | | SMILES: | Fc1ccc(cc1)CC(N)C(=O)NC(Cc1ccc(F)cc1)C(=O)NC(CC1CCNC1=O)CCC(=O)OCC | | InChi: | InChI=1S/C29H36F2N4O5/c1-2-40-26(36)12-11-23(17-20-13-14-33-27(20)37)34-29(39)25(16-19-5-9-22(31)10-6-19)35-28(38)24(32)15-18-3-7-21(30)8-4-18/h3-10,20,23-25H,2,11-17,32H2,1H3,(H,33,37)(H,34,39)(H,35,38)/t20-,23+,24+,25-/m0/s1 | | 定義日: | 2021-04-01 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-10-12 | | 識別子(ID): | 4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide |
|
 | | Y4J | | 表記: | (1R,2S)-2-((S)-2-(((((1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | | 組成式: | C24 H39 N3 O8 S | | SMILES: | N(C(=O)C(CC(C)C)NC(OCC1CC2CC(C1)CC=C2)=O)C(CC3C(NCC3)=O)C(O)S(=O)(O)=O | | InChi: | InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19-,20-,23+/m0/s1 | | 定義日: | 2021-02-03 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-02-17 | | 識別子(ID): | (1R,2S)-2-{[N-({[(1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | WJB | | 表記: | (1R,2S)-2-[(N-{[2-(benzenesulfonyl)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | | 組成式: | C24 H37 N3 O10 S2 | | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)S(=O)(=O)c1ccccc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C24H37N3O10S2/c1-15(2)12-18(21(29)26-19(22(30)39(34,35)36)13-16-10-11-25-20(16)28)27-23(31)37-14-24(3,4)38(32,33)17-8-6-5-7-9-17/h5-9,15-16,18-19,22,30H,10-14H2,1-4H3,(H,25,28)(H,26,29)(H,27,31)(H,34,35,36)/t16-,18-,19-,22+/m0/s1 | | 定義日: | 2022-09-13 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-09-21 | | 識別子(ID): | (1R,2S)-2-[(N-{[2-(benzenesulfonyl)-2-methylpropoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | NZC | | 表記: | N-methylidene-L-threonine | | 組成式: | C5 H11 N O3 | | SMILES: | O=C(O)C(NC)C(O)C | | InChi: | InChI=1S/C5H11NO3/c1-3(7)4(6-2)5(8)9/h3-4,6-7H,1-2H3,(H,8,9)/t3-,4+/m1/s1 | | 定義日: | 2015-02-05 | | 最終更新日: | 2024-09-27 | | 公開日: | 2015-06-03 | | 識別子(ID): | N-methyl-L-threonine |
|
 | | YVG | | 表記: | D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide | | 組成式: | C29 H38 N4 O5 | | SMILES: | NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CC1CCNC1=O)CCC(=O)OCC | | InChi: | InChI=1S/C29H38N4O5/c1-2-38-26(34)14-13-23(19-22-15-16-31-27(22)35)32-29(37)25(18-21-11-7-4-8-12-21)33-28(36)24(30)17-20-9-5-3-6-10-20/h3-12,22-25H,2,13-19,30H2,1H3,(H,31,35)(H,32,37)(H,33,36)/t22-,23+,24+,25-/m0/s1 | | 定義日: | 2021-04-01 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-10-12 | | 識別子(ID): | D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide |
|
 | | S1K | | 表記: | 2-(5-(benzyloxy)-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acetic acid | | 組成式: | C16 H15 B O5 | | SMILES: | OB1O[CH](CC(O)=O)c2cc(OCc3ccccc3)ccc12 | | InChi: | InChI=1S/C16H15BO5/c18-16(19)9-15-13-8-12(6-7-14(13)17(20)22-15)21-10-11-4-2-1-3-5-11/h1-8,15,20H,9-10H2,(H,18,19)/t15-/m0/s1 | | 別名: | 2-[(3S)-1-oxidanyl-5-phenylmethoxy-3H-2,1-benzoxaborol-3-yl]ethanoic acid | | 定義日: | 2020-11-05 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-08-11 | | 識別子(ID): | 2-[(3~{S})-1-oxidanyl-5-phenylmethoxy-3~{H}-2,1-benzoxaborol-3-yl]ethanoic acid |
|
 | | UUH | | 表記: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol | | 組成式: | C26 H36 B F2 N5 O4 | | SMILES: | Cc1cc(C)c2n1[B-](F)(F)[N+]3=C(C)C=C(C)C3=C2CCCCc4cn(C[CH]5[CH](O)C[CH](O)[CH](O)[CH]5O)nn4 | | InChi: | InChI=1S/C26H36BF2N5O4/c1-14-9-16(3)33-23(14)19(24-15(2)10-17(4)34(24)27(33,28)29)8-6-5-7-18-12-32(31-30-18)13-20-21(35)11-22(36)26(38)25(20)37/h9-10,12,20-22,25-26,35-38H,5-8,11,13H2,1-4H3/t20-,21-,22-,25+,26+/m0/s1 | | 定義日: | 2021-03-19 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-03-30 | | 識別子(ID): | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol |
|
 | | NKK | | 表記: | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide | | 組成式: | C29 H44 N8 O4 | | SMILES: | O=CC(NC(=O)C(NC(=O)C(NC(=O)c2ccc1c(cccc1)c2)CCCCN)CCCCN)CCCNC(=[N@H])N | | InChi: | InChI=1S/C29H44N8O4/c30-15-5-3-11-24(27(40)35-23(19-38)10-7-17-34-29(32)33)37-28(41)25(12-4-6-16-31)36-26(39)22-14-13-20-8-1-2-9-21(20)18-22/h1-2,8-9,13-14,18-19,23-25H,3-7,10-12,15-17,30-31H2,(H,35,40)(H,36,39)(H,37,41)(H4,32,33,34)/t23-,24-,25-/m0/s1 | | 定義日: | 2008-08-22 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide |
|
 | | SV6 | | 表記: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | | 組成式: | C36 H55 N7 O6 | | SMILES: | O=C(NC1CC1)C(O)C(NC(=O)C4N(C(=O)C(NC(=O)C(NC(=O)c2nccnc2)C3CCCCC3)C(C)(C)C)CC5CCCC45)CCC | | InChi: | InChI=1S/C36H55N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-30,44H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,29+,30+/m0/s1 | | 別名: | TELAPREVIR, bound form | | 定義日: | 2011-08-08 | | 最終更新日: | 2024-09-27 | | 公開日: | 2012-08-31 | | 識別子(ID): | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide (non-preferred name) |
|
 | | XCP | | 表記: | (1S,2S)-2-aminocyclopentanecarboxylic acid | | 組成式: | C6 H11 N O2 | | SMILES: | O=C(O)C1CCCC1N | | InChi: | InChI=1S/C6H11NO2/c7-5-3-1-2-4(5)6(8)9/h4-5H,1-3,7H2,(H,8,9)/t4-,5-/m0/s1 | | 定義日: | 2008-02-05 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (1S,2S)-2-aminocyclopentanecarboxylic acid |
|
 | | W41 | | 表記: | 6-chlorotetrazolo[1,5-b]pyridazine | | 組成式: | C4 H2 Cl N5 | | SMILES: | n2nc1n(nc(Cl)cc1)n2 | | InChi: | InChI=1S/C4H2ClN5/c5-3-1-2-4-6-8-9-10(4)7-3/h1-2H | | 定義日: | 2020-09-24 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-01-13 | | 識別子(ID): | 6-chlorotetrazolo[1,5-b]pyridazine |
|
 | | NKL | | 表記: | 2-chloranyl-1-[2-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | | 組成式: | C21 H27 Cl2 N3 O3 | | SMILES: | ClCC(=O)N1CCC2(CC1)CN(C2)C(=O)C3(CCOCC3)Nc4ccc(Cl)cc4 | | InChi: | InChI=1S/C21H27Cl2N3O3/c22-13-18(27)25-9-5-20(6-10-25)14-26(15-20)19(28)21(7-11-29-12-8-21)24-17-3-1-16(23)2-4-17/h1-4,24H,5-15H2 | | 定義日: | 2022-08-17 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-09-20 | | 識別子(ID): | 2-chloranyl-1-[2-[4-[(4-chlorophenyl)amino]oxan-4-yl]carbonyl-2,7-diazaspiro[3.5]nonan-7-yl]ethanone |
|
 | | N6K | | 表記: | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide | | 組成式: | C10 H13 N3 O2 S | | SMILES: | CC[S](=O)(=O)NCc1ccc2[nH]ncc2c1 | | InChi: | InChI=1S/C10H13N3O2S/c1-2-16(14,15)12-6-8-3-4-10-9(5-8)7-11-13-10/h3-5,7,12H,2,6H2,1H3,(H,11,13) | | 別名: | N-(1H-indazol-5-ylmethyl)ethenesulfonamide (precursor) | | 定義日: | 2022-08-12 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-09-28 | | 識別子(ID): | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide |
|
 | | VOL | | 表記: | L-VALINOL | | 組成式: | C5 H13 N O | | SMILES: | OCC(N)C(C)C | | InChi: | InChI=1S/C5H13NO/c1-4(2)5(6)3-7/h4-5,7H,3,6H2,1-2H3/t5-/m1/s1 | | 定義日: | 2002-06-26 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (2S)-2-amino-3-methylbutan-1-ol |
|
 | | PN7 | | 表記: | N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide | | 組成式: | C11 H23 N2 O7 P S | | SMILES: | OC(C(C)(COP(O)(O)=O)C)C(=O)NCCC(NCCS)=O | | InChi: | InChI=1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/t9-/m1/s1 | | 定義日: | 2015-07-16 | | 最終更新日: | 2024-09-27 | | 公開日: | 2016-01-20 | | 識別子(ID): | N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide |
|
 | | YVJ | | 表記: | 4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide | | 組成式: | C29 H37 F N4 O5 | | SMILES: | Fc1ccc(cc1)CC(N)C(=O)NC(Cc1ccccc1)C(=O)NC(CC1CCNC1=O)CCC(=O)OCC | | InChi: | InChI=1S/C29H37FN4O5/c1-2-39-26(35)13-12-23(18-21-14-15-32-27(21)36)33-29(38)25(17-19-6-4-3-5-7-19)34-28(37)24(31)16-20-8-10-22(30)11-9-20/h3-11,21,23-25H,2,12-18,31H2,1H3,(H,32,36)(H,33,38)(H,34,37)/t21-,23+,24+,25-/m0/s1 | | 定義日: | 2021-04-01 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-10-12 | | 識別子(ID): | 4-fluoro-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide |
|
 | | Y4P | | 表記: | (1R,2S)-2-((S)-2-(((((1R,2S,4S)-bicyclo[2.2.1]heptan-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | | 組成式: | C22 H37 N3 O8 S | | SMILES: | CC(C)C[CH](NC(=O)OC[CH]1C[CH]2CC[CH]1C2)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)[S](O)(=O)=O | | InChi: | InChI=1S/C22H37N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h12-18,21,28H,3-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21+/m0/s1 | | 定義日: | 2021-02-03 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-02-17 | | 識別子(ID): | (2~{S})-2-[[(2~{S})-2-[[(1~{R},2~{S},4~{S})-2-bicyclo[2.2.1]heptanyl]methoxycarbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | UUK | | 表記: | tert-butyl (1-((4-(dibenzylamino)-4-oxobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate | | 組成式: | C29 H41 N3 O4 | | SMILES: | CC(C)C[CH](NC(=O)OC(C)(C)C)C(=O)NCCCC(=O)N(Cc1ccccc1)Cc2ccccc2 | | InChi: | InChI=1S/C29H41N3O4/c1-22(2)19-25(31-28(35)36-29(3,4)5)27(34)30-18-12-17-26(33)32(20-23-13-8-6-9-14-23)21-24-15-10-7-11-16-24/h6-11,13-16,22,25H,12,17-21H2,1-5H3,(H,30,34)(H,31,35)/t25-/m0/s1 | | 別名: | ~{tert}-butyl ~{N}-[(2~{S})-1-[[4-[bis(phenylmethyl)amino]-4-oxidanylidene-butyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate | | 定義日: | 2021-03-19 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-09-08 | | 識別子(ID): | ~{tert}-butyl ~{N}-[(2~{S})-1-[[4-[bis(phenylmethyl)amino]-4-oxidanylidene-butyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate |
|
 | | PN8 | | 表記: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[($l^{5}-azanylidyne-$l^{5}-azanyl)amino]methyl]cyclohexane-1,2,3,5-tetrol | | 組成式: | C7 H14 N3 O4 | | SMILES: | O[CH]1C[CH](O)[CH](CN[N]#N)[CH](O)[CH]1O | | InChi: | InChI=1S/C7H14N3O4/c8-10-9-2-3-4(11)1-5(12)7(14)6(3)13/h3-7,9,11-14H,1-2H2/t3-,4-,5-,6+,7+/m0/s1 | | 定義日: | 2020-04-26 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-05-12 | | 識別子(ID): | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[(azanylidyne-$l^{4}-azanyl)amino]methyl]cyclohexane-1,2,3,5-tetrol |
|
 | | NZH | | 表記: | (2S)-2-AMINO-3-[1-(1H-TETRAAZOL-5-YL)-1H-IMIDAZOL-4-YL]PROPANAL | | 組成式: | C7 H9 N7 O | | SMILES: | O=CC(N)Cc2ncn(c1nnnn1)c2 | | InChi: | InChI=1S/C7H9N7O/c8-5(3-15)1-6-2-14(4-9-6)7-10-12-13-11-7/h2-5H,1,8H2,(H,10,11,12,13)/t5-/m0/s1 | | 別名: | TETRAZOLYL HISTIDINE | | 定義日: | 2004-12-28 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (2S)-2-amino-3-[1-(1H-tetrazol-5-yl)-1H-imidazol-4-yl]propanal |
|
 | | SVA | | 表記: | SERINE VANADATE | | 組成式: | C3 H7 N O7 V | | SMILES: | [O-][V]([O-])([O-])(O)OCC(N)C(=O)O | | InChi: | InChI=1S/C3H6NO3.H2O.3O.V/c4-2(1-5)3(6)7 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | For multi-component charged structures, a total zero charge is required! |
|
 | | LK5 | | 表記: | (1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID | | 組成式: | C17 H27 N O4 | | SMILES: | O=CC(C2NC(=C1C(OCCCC)CCCC12)C(=O)O)CC | | InChi: | InChI=1S/C17H27NO4/c1-3-5-9-22-13-8-6-7-12-14(13)16(17(20)21)18-15(12)11(4-2)10-19/h10-13,15,18H,3-9H2,1-2H3,(H,20,21)/t11-,12+,13+,15+/m0/s1 | | 定義日: | 2007-06-15 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (1S,4R,7aR)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid |
|
 | | YVM | | 表記: | 4-fluoro-N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide | | 組成式: | C35 H43 F N4 O7 | | SMILES: | Fc1ccc(cc1)CC(NC(=O)CCOCC#C)C(=O)NC(Cc1ccccc1)C(=O)NC(CC1CCNC1=O)CCC(=O)OCC | | InChi: | InChI=1S/C35H43FN4O7/c1-3-19-46-20-17-31(41)39-29(22-25-10-12-27(36)13-11-25)35(45)40-30(21-24-8-6-5-7-9-24)34(44)38-28(14-15-32(42)47-4-2)23-26-16-18-37-33(26)43/h1,5-13,26,28-30H,4,14-23H2,2H3,(H,37,43)(H,38,44)(H,39,41)(H,40,45)/t26-,28+,29+,30-/m0/s1 | | 定義日: | 2021-04-01 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-10-12 | | 識別子(ID): | 4-fluoro-N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-phenylalaninamide |
|